Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02438930
Other study ID # SK_UG_K01
Secondary ID K01MH083536
Status Completed
Phase N/A
First received May 6, 2015
Last updated May 7, 2015
Start date May 2008
Est. completion date March 2012

Study information

Verified date May 2015
Source University of Connecticut Health Center
Contact n/a
Is FDA regulated No
Health authority Uganda: National Council for Science and TechnologyUnited States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This study pilot tests and intervention to help individuals reduce their risk for acquiring or transmitting HIV. The intervention is implemented when people are tested for HIV in an outpatient clinic in rural Uganda. Approximately half of participants will receive the intervention and the other half will receive the usual counseling provided during HIV counseling and testing.


Recruitment information / eligibility

Status Completed
Enrollment 333
Est. completion date March 2012
Est. primary completion date February 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. at least 18 years of age,

2. have come to the outpatient clinic for a medical concern (e.g., cough, malaria, but not those seeking voluntary HIV-counseling and testing,

3. sexually active within the prior 3-months,

4. not currently pregnant,

5. no confirmed HIV-positive test result prior to the present HIV-test, and

6. live not more than 30km from Gombe Hospital in Uganda (to facilitate follow-up)

Exclusion Criteria:

- less than 18 years of age,

- having come to the clinic seeking voluntary HIV-counseling and testing,

- not sexually active in prior 3 months,

- currently pregnant,

- confirmed prior HIV positive test,

- live more than 30km from the hospital

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
Motivational interviewing intervention during HIV testing

Standard-of-care counseling during HIV testing


Locations

Country Name City State
Uganda Gombe Hospital Gombe

Sponsors (4)

Lead Sponsor Collaborator
Susan M. Kiene Makerere University, National Institute of Mental Health (NIMH), Rhode Island Hospital

Country where clinical trial is conducted

Uganda, 

References & Publications (1)

Kiene SM, Sileo K, Wanyenze RK, Lule H, Bateganya MH, Jasperse J, Nantaba H, Jayaratne K. Barriers to and acceptability of provider-initiated HIV testing and counselling and adopting HIV-prevention behaviours in rural Uganda: a qualitative study. J Health Psychol. 2015 Feb;20(2):173-87. doi: 10.1177/1359105313500685. Epub 2013 Sep 20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Sexual risk behavior Unprotected sex with serodiscordant or unknown HIV status partners 6 months No
Secondary Uptake of partner testing Partner uptake of HIV testing 6 months No
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Active, not recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2